OBIO
Orchestra BioMed Holdings Inc.
6.00$
+3.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
Orchestra BioMed Holdings Inc. (OBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.2 | -5.6 | -4.4 | -4.8 | -4.6 | -5.3 | -9.1 | -7.3 | -8.7 | -14 | -10 | -10 | -11 | -13 | -10 | -14 | -14 | -17 | -16 | -15 | -2.3 | -22 | -19 | -58 | |
| – | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | |
| – | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.3 | 2.2 | 0.9 | 1.5 | 1.7 | 3.5 | 0.9 | 2.6 | 2.8 | 2.4 | 2.9 | 3.0 | 3.3 | 3.0 | 2.8 | 2.9 | 2.5 | 11 | |
| – | – | – | – | – | – | – | 2.7 | 0.8 | 0.8 | 0.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.2 | 0.2 | -0.1 | -0.1 | 0.1 | -0.3 | -0.6 | 0.3 | 0.1 | -4.4 | 0.6 | 0.6 | -0.1 | -1.8 | 3.1 | -1.2 | -1.4 | -1.0 | 0.4 | 2.5 | -12 | -3.7 | 0.1 | -13 | |
| 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.0 | 0.2 | 0.3 | 0.8 | |
| -160 | 0.7 | 6.3 | 6.3 | -0.3 | 0.0 | -0.5 | -0.2 | -63 | -44 | 8.1 | 13 | 33 | 5.9 | 10 | 0.6 | -3.8 | 13 | 16 | -39 | -18 | 10 | -23 | -69 | |
| – | – | – | – | – | – | – | -93 | -110 | – | – | – | – | – | – | – | – | – | -0.4 | – | – | – | -0.6 | – | |
| 162 | -1.0 | -1.0 | -1.0 | -1.0 | 25 | 87 | -2.5 | -5.1 | 57 | 0.1 | 0.0 | -11 | 0.0 | 0.2 | 15 | 14 | -0.3 | -0.4 | 76 | 13 | 5.5 | 35 | 129 | |
| 1.8 | -5.8 | 0.9 | 0.4 | -5.9 | 19 | -0.1 | -10.0 | 19 | -1.1 | -2.3 | 2.7 | 11 | -7.2 | 0.4 | 1.9 | -3.3 | -3.9 | 0.4 | 23 | -7.3 | -6.3 | -7.9 | 1.7 | |
| -0.2 | -5.7 | -4.4 | -4.9 | -4.7 | -5.4 | -9.4 | -7.5 | -8.8 | -14 | -11 | -10 | -11 | -13 | -10 | -14 | -14 | -17 | -16 | -15 | -2.3 | -22 | -20 | -59 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.